Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations
Marino, A.; Munafò, A.; Augello, E.; Bellanca, C.M.; Bonomo, C.; Ceccarelli, M.; Musso, N.; Cantarella, G.; Cacopardo, B.; Bernardini, R. Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations. Infect. Dis. Rep. 2022, 14, 360-371. https://doi.org/10.3390/idr14030040
Marino A, Munafò A, Augello E, Bellanca CM, Bonomo C, Ceccarelli M, Musso N, Cantarella G, Cacopardo B, Bernardini R. Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations. Infectious Disease Reports. 2022; 14(3):360-371. https://doi.org/10.3390/idr14030040
Chicago/Turabian StyleMarino, Andrea, Antonio Munafò, Egle Augello, Carlo M. Bellanca, Carmelo Bonomo, Manuela Ceccarelli, Nicolò Musso, Giuseppina Cantarella, Bruno Cacopardo, and Renato Bernardini. 2022. "Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations" Infectious Disease Reports 14, no. 3: 360-371. https://doi.org/10.3390/idr14030040